Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes

CompletedOBSERVATIONAL
Enrollment

1,204

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

April 11, 2019

Study Completion Date

April 11, 2019

Conditions
Peripheral Arterial Occlusive Disease
Interventions
OTHER

PAD endovascular treatments

All FDA-cleared endovascular PAD treatments

Trial Locations (52)

10001

Gotham Cardiovascular Research, New York

10032

Columbia University Medical Center, New York

20850

Shady Grove Adventist Hospital, Rockville

27607

Rex Heathcare, Raleigh

28358

Duke University Hospital, Lumberton

32216

First Coast Cardiovascular Institute, Jacksonville

32504

Coastal Vascular and Intervention, Pensacola

32803

Florida Hospital, Orlando

33140

Mount Sinai Medical Center Heart Institute, Miami Beach

33176

Baptist Cardiac and Vascular Institute, Miami

33613

Pepin Heart Institute, Tampa

33756

Clearwater Cardiovascular Consultants, Clearwater

33770

The Heart Institute of Largo, Largo

33805

Lakeland Regional Medical Center, Lakeland

37403

University Surgical Associates, Chattanooga

37660

Wellmont CVA Heart Institute, Kingsport

37909

Premier Surgical Associates, Knoxville

38671

Stern Cardiovascular Foundation, Southaven

40504

St. Joseph Hospital, Lexington

43214

Ohio Health, Columbus

48126

Michigan Outpatient Vascular Institute, Dearborn

48236

St. John Hospital and Medical Center, Detroit

48604

Mid-Michigan Heart and Vascular Center, Saginaw

49519

Metro Health Hospital, Wyoming

52803

Midwest Cardiovascular Research Foundation, Davenport

55433

Metropolitan Heart and Vascular Institute, Coon Rapids

57104

Sanford Research, Sioux Falls

60173

Chicago Vascular Clinic, Schaumburg

62701

St. John's Hospital Springfield, Springfield

62902

Memorial Hospital Carbondale, Carbondale

64111

St. Luke's Hospital, Kansas City

65802

Cox Health System, Springfield

72211

Arkansas Heart Hospital, Little Rock

74104

St. John Health System, Tulsa

75701

Cardiovascular Associates of East Texas, Tyler

76712

Providence Health Services, Waco

77030

Houston Methodist Research Institute, Houston

77479

Houston Methodist Research Institute Sugar Land, Sugar Land

77555

University of Texas Medical Branch at Galveston, Galveston

78130

Mission Research Institute, New Braunfels

78358

San Antonio Endovascular & Heart Institute, San Antonio

78756

Cardiothoracic and Vascular Surgeons, P.A., Austin

79902

El Paso Cardiology Associates, El Paso

80220

Denver Heart, Denver

VA Eastern Colorado Healthcare System, Denver

80228

Colorado Heart and Vascular, PC, Lakewood

85006

St. Luke's Medical Center, Phoenix

85297

Mercy Gilbert Medical Center, Gilbert

85306

Phoenix Heart Cardiovascular, Glendale

90048

Cedars-Sinai Heart Institute, Los Angeles

06102

Hartford Hospital, Hartford

06510

Yale-New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT01855412 - Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes | Biotech Hunter | Biotech Hunter